Storing semaglutide at room temperature or warmer temperatures can degrade the active peptide, reducing its effectiveness for weight loss and metabolic control
Individual responses vary depending on the condition being addressed and baseline nutritional status
Neumann J, Hadova K, Klimas J, Hofmann B, Gergs U (2024) Contractile effects of semaglutide in the human atrium
Dipeptidyl peptidase 4 inhibitors and their potential immune modulatory functions
Y.PiaoX
Originally developed for the treatment of type 2 diabetes mellitus, these agentsincluding semaglutide and tirzepatidehave demonstrated substantial efficacy in promoting weight loss and are increasingly reshaping therapeutic strategies for obesity, cardiovascular and kidney disease, and potentially substance use disorders.[1,2] Historically, paradigm-shifting therapeutics have periodically redefined clinical practice